Pity the poor radiologists.

Or, as we'll find out, the rich radiologists.

Ten years ago, Geoffrey Hinton – known as one of the three "Godfathers of AI" – predicted they'd be replaced by computers.

He had a good argument...

Radiologists spend their days reviewing X-rays, MRIs, and other imaging results to diagnose patients. It's a bit of an odd specialty... involving less bedside patient care and more time staring at a computer screen.

And at the time of Hinton's prediction, AI had already made big advances in image recognition. By reviewing thousands of already diagnosed images, a machine-learning program could deliver results as accurately as a human – and much faster.

So everyone started thinking: If a computer can read scans as well as a radiologist, why do we need radiologists at all?

Fast-forward to today...

Radiologists are still the third-highest-paid specialists in the medical field, earning an average of $571,000 per year, as of 2025. That's up 9% from the prior year and tied with ophthalmologists for the second-largest gain.

On top of that, the U.S. actually has a shortage of radiologists.

So, what happened?

Hinton wasn't wrong about technology. AI image recognition got very good very quickly. And radiologists use it all the time.

Rather, Hinton was wrong about how technology interacted with society.

According to a 2025 report from the Journal of the American Medical Association, AI has made radiologists 40% more productive. And since hospitals get paid per test, that means a single radiologist can make them 40% more money.

So hospitals want more radiologists today. Not fewer.

There's an important lesson here...

The people closest to AI may know a lot about how the technology works and what it will do in the future.

But they don't know any more than we do about how it will really affect the world. That's a question for economists, sociologists, policymakers, and philosophers.

Perhaps AI experts know how advanced the technology will get and how quickly – but it's entirely possible they're caught in a frenzy of groupthink.

Mustafa Suleyman, the CEO of Microsoft AI, told the Financial Times this February that white-collar workers such as lawyers, accountants, and project managers will be fully automated by AI within the next year or so.

Anthropic CEO Dario Amodei proclaimed last year that AI could wipe out half of all entry-level white-collar jobs within five years.

We know to ignore such nonsense...

If AI makes people more productive, companies will want to hire more of them. Productivity increases output, leads to new opportunities, and raises the value of skilled workers. The radiology example proves it.

In all cases, aside from AI reaching a point of true superintelligence, that's the pattern we expect to see.

Could there be a rise in unemployment? Yes. Will certain roles become obsolete, resulting in individuals losing jobs and needing to retrain for different roles? Also, yes.

But keep in mind, the AI leaders making bold predictions also have big reasons to push the AI story. They're trying to hype up their own tech to keep boosting their valuations.

History suggests there will still be jobs. More productive workers won't become irrelevant. They'll become more valuable.

But folks love to forecast that AI will make entire companies obsolete...

Right now, there's one particular giant that the market has soured on because of its uncertain relationship with AI. However, we'd argue that – like radiologists – this company will only get better with AI.

It's a cash-gushing business that's trading at an extremely low valuation. We believe it's easily one of the best deals in the market today. And as the company makes moves to adapt to and integrate AI, it'll only become stronger.

Retirement Millionaire subscribers can read all about this opportunity by clicking here.

And if you aren't a Retirement Millionaire subscriber but would like to learn more about joining, click here.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
August 19, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top